We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Donor Platelet Activation Varies by Time of Day

By LabMedica International staff writers
Posted on 13 Jun 2022

Platelets, are anucleate cells produced by megakaryocytes in the bone marrow that circulate in the bloodstream for about 10 days. More...

Circulating platelets play a central role in the hemostatic response to vascular injury. They are also involved in maintaining vascular integrity and contributed to immune and inflammatory responses.

Platelet donors, like whole blood and plasma donors, are considered to be one of the healthiest groups of the general population. A number of factors may influence the in vivo platelet activation state in healthy individuals. In particular, platelet activation has been shown to vary according to the time of day, with the highest measured levels during the morning hours.

Hematologist at the Akershus University Hospital (Lørenskog, Norway) collected whole blood samples from 86 platelet donors presenting at their Blood Bank between April 2019 and February 2020. The mean age was 50.8 ± 9.7 years with 56% of donors were female. Samples were collected from the attached sampling bags (containing 42 mL whole blood collected immediately before plateletpheresis) using standard vacutainers. A blood sample was collected into a citrated tube for flow cytometric determination of platelet surface P-selectin expression.

For flow cytometry, 100 µL of citrated blood (diluted 1:20 with phosphate-buffered saline [PBS] containing 0.1% bovine serum albumin [BSA], pH 7.4) was incubated at room temperature with FITC-conjugated anti-CD61 (5 µL) and PE-conjugated anti-CD62P (10 µL) for 15 minutes. Background fluorescence was assessed by labeling diluted samples with 10 µL PE-conjugated isotype control antibody. After incubating, the samples were diluted to 4 mL with PBS/BSA and analyzed immediately on a FACS Canto II flow cytometer (BD Bioscience, San Jose, CA, USA). The percentage of activated platelets (i.e., CD61 and CD62P double-positive platelets) was obtained from a total of 10,000 recorded events with the CD61+ gate.

The investigators reported that the percentage of activated (i.e., P-selectin-expressing) platelets in pre-donation blood samples ranged from 0.2% to 7.5% (1.85 ± 1.57%; median, 1.3%; IQR, 0.8–2.3%). Twenty-seven donors (32%) had less than 1.0% activated platelets, and five donors (6%) had more than 5.0% activated platelets, indicating considerable donor variability in the levels of circulating activated platelets.

The percentage of activated platelets was significantly and inversely correlated with the collection time (i.e., the time of day blood samples were collected) and positively correlated to mean platelet volume (MPV). A weaker positive correlation was also observed with ABO blood group. Analysis of the collection time as a categorical variable showed a greater degree of activated platelets in samples collected between 08:00 and 10:00 than in samples collected during the hours after 10:00 to 14:00 (2.5 ± 1.8 versus 1.1 ± 0.74).

The authors concluded that their results showed that platelet activation was significantly and inversely associated with the collection time by univariate analysis and after adjustment for covariates. The study also showed that blood group A was associated with higher platelet activation. This work may have implications for optimizing the timing of platelet donation, if, for example, the temporal variation in platelet activation at the time of donation can impact the final heterogeneity of the stored platelet concentrates and, potentially, transfusion outcomes. The study was published on June 3 2022 in the Journal of Blood Medicine.

Related Links:
Akershus University Hospital 
BD Bioscience 


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Serological Pipet Controller
PIPETBOY GENIUS
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
New
Shaking Incubator
Corning LSE 71L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.